Europe's Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats.

CARE a new consortium announced its launched to accelerate the discovery and development of urgently needed medicines to treat SARS-CoV-2, the virus...

AstraZeneca concludes agreement with the EC for the supply of up to 400 million doses of AZD1222 COVID-19 vaccine.

AstraZeneca has concluded an agreement with the EC to supply up to 400 million doses of the AZD1222 COVID-19 vaccine. Building on the existing agreement with Europe's Inclusive Vaccines..

China grants country's first Covid-19 vaccine patent to CanSino.

China's vaccine maker CanSino Biologics Inc has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, People's Daily reported, citing documents from the country's intellectual property...

Novavax Initiates Efficacy Trial of COVID-19 Vaccine in South Africa.

Novavax announced the beginning of a Phase 2b clinical trial in South Africa to evaluate the efficacy of NVX-CoV2373, Novavax COVID-19 vaccine candidate.

DSG and Bestat Partner in Building COVID-19 Clinical Trials in Singapore.

DSG along with their CRO partner, Bestat Pharmaservices Corp. are building studies to support COVID-19 treatments and vaccines in Asia.

SAB Bio Announces First Participant Dosed In Phase 1 Clinical Trial Of SAB-185 For The Treatment And Prevention Of COVID-19.

SAB Biotherapeutics announced that the first participant has been dosed in its Phase 1 study evaluating the safety of SAB-185,...

OSE Immunotherapeutics Publishes Positive Preclinical COVID-19 Vaccine Results With Multi-Target Vaccine CoVepiT.

OSE Immunotherapeutics announced the online publication in BioRxiv of positive data from preclinical and human ex vivo studies with CoVepiT...

Roche and Regeneron collaborate to significantly increase global supply of REGN-COV2 investigational antibody combination for COVID-19.

Roche and Regeneron announced that they are joining forces in the fight against COVID-19 to develop, manufacture and distribute REGN-COV2...

Qu Biologics Initiates Phase 2 Study to Assess Activation of Anti-cancer Immune Response in Colon Cancer.

Qu Biologics Inc, is pleased to announce approval from the Israeli Ministry of Health to proceed with their clinical trial of QBECO SSI in patients with colorectal cancer.

Therapure Biomanufacturing Signs Manufacturing Deal With VBI Vaccines for Coronavirus Vaccine Candidates.

Therapure Biomanufacturing, a division of Therapure Biopharma Inc., announced today the signing of an agreement with VBI Vaccines Inc. for the manufacture of their coronavirus vaccine candidates. . ..